| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 170, 1887-1896, August 2005, Copyright © 2005
doi:10.1534/genetics.105.044222
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* Hubrecht Laboratory, Centre for Biomedical Genetics, 3584 CT Utrecht, The Netherlands
Department of Otorhinolaryngology, Radboud University, 6500 HB Nijmegen, The Netherlands
Department of Cell Biology, Radboud University, 6500 HB Nijmegen, The Netherlands
1 Corresponding author: Functional Genomics Group, Hubrecht Laboratory, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
E-mail: ecuppen{at}niob.knaw.nl
| ABSTRACT |
|---|
|
|
|---|
Several large-scale mouse forward genetic screens for ENU-induced mutations have been initiated (reviewed in KEAYS and NOLAN 2003). The screens are phenotype driven, employing appropriate assays on mutant animals to identify phenotypes that resemble aspects of human disease. The resulting models are expected to contribute substantially to the understanding of genetic diseases (COX and BROWN 2003).
For the rat, however, the >200 existing models (HEDRICH 2000; JACOB and KWITEK 2002) are primarily selected from existing laboratory strains and their number and nature is therefore limited by the degree of naturally occurring variation or the occurrence of spontaneous novel mutations. Nevertheless, important rat models exist for common human diseases (GREENHOUSE et al. 1990), including hypertension, diabetes, cancer, and many others (JACOB et al. 1992; SHEPEL et al. 1998; RAPP 2000). ENU mutagenesis would have the potential to induce a major increase in the number of rat phenotypes and models, as it has done for the mouse (BROWN and NOLAN 1998; BROWN and BALLING 2001).
While ENU mutagenesis conditions have recently been established for the rat (ZAN et al. 2003; SMITS et al. 2004), additional bottlenecks for efficient forward genetics are still present. First, establishment of comprehensive and efficient high-throughput screening setups will be challenging, although the rat has already been used for decades as the primary model organism in, for example, behavioral neurobiology, hypertension, and diabetes research. As a result, extensively validated assays are available and provide a solid basis for the development of a rat screening protocol. Second, cloning of the causal mutations underlying aberrant phenotypes depends on the availability of efficient genetic mapping and cloning tools. Currently, the availability of genetic markers to scan the rat genome for linkage to traits of interest is limited. Although a large collection of microsatellite markers has been genotyped in variety of strains and successfully used for mapping and cloning purposes (CHWALISZ et al. 2003; KURAMOTO et al. 2004), the application of the more versatile single nucleotide polymorphism (SNP) markers in the rat is still in its infancy. Large repositories of rat SNPs and candidate SNPs became available recently (GURYEV et al. 2004; ZIMDAHL et al. 2004), but information on SNP distribution in different strains is still mostly lacking.
In this study, we describe the identification and characterization of the first autosomal recessive mutant rat strain from an ENU mutagenesis-driven study. Animals from this strain display locomotory hyperactivity, circling behavior, and stereotypic head shaking. More detailed characterization reveals that these animals are deaf due to progressive degeneration of the organ of Corti. For mapping and cloning purposes, we designed and tested a genome-wide SNP-based mapping panel for Wistar vs. Brown Norway (BN)-based crosses, which allowed us to pinpoint the mutation to a chromosomal subregion containing a limited number of strong candidate genes. With the subsequent identification of a premature stopcodon in one of these genes, Myo7a, we established a rat model for the human Usher syndrome type 1B (USH1B) and provided proof of concept for ENU-driven forward genetics in the rat.
| MATERIALS AND METHODS |
|---|
|
|
|---|
For the mapping cross, two male tornado animals ware mated with four Brown Norway females (BN/Crl). From the F1 generation, 10 males and 10 females were intercrossed to restore the tornado phenotype.
DNA isolation, PCR, and sequencing:
For genotyping, animals were tail clipped under isoflurane anesthetics. Lysis on tail clips was done overnight at 55° in 400 µl lysis buffer, containing 100 mM Tris (pH 8.5), 200 mM of NaCl, 0.2% of SDS, 5 mM of EDTA, and 100 µg/ml of freshly added proteinase K. Samples were centrifuged for 15 min at 6000 x g and the supernatant was transferred to a fresh tube or plate. Genomic DNA was isolated by adding an equal amount of isopropanol, mixing, and subsequently centrifuging for 20 min at 6000 x g. Pellets were rinsed with 70% ethanol and dissolved in 400 µl H2O. For PCR, 5 µl of a 50x dilution in water was used.
PCR was carried out using a touchdown thermocycling program (92° for 60 sec; 12 cycles of 92° for 20 sec, 65° for 20 sec with a decrement of 0.4° per cycle, 72° for 30 sec; followed by 20 cycles of 92° for 20 sec, 58° for 20 sec, and 72° for 30 sec; and 72° for 180 sec; GeneAmp9700, Applied Biosystems, Foster City, CA). PCR reaction mixes contained 5 µl genomic DNA, 0.2 µM forward primer, and 0.2 µM reverse primer, 200 µM of each dNTP, 25 mM tricine, 7.0% glycerol (w/v), 1.6% DMSO (w/v), 2 mM MgCl2, 85 mM ammonium acetate, pH 8.7, and 0.2 units Taq polymerase in a total volume of 10 µl.
PCR products were diluted with 25 µl water and 1 µl was used as template for the sequencing reactions. Sequencing reactions, containing 0.25 µl BigDYE (v1.1; Applied Biosystems), 3.75 µl 2.5x dilution buffer (Applied Biosystems), and 0.4 µM gene-specific primer in a total volume of 10 µl, were performed using cycling conditions recommended by the manufacturer. Sequencing products were purified by ethanol precipitation in the presence of 40 mM sodium acetate and analyzed on a 96-capillary 3730XL DNA analyzer (Applied Biosystems). Sequences were analyzed for the presence of polymorphisms using polyphred (NICKERSON et al. 1997). Primers for PCR amplification and sequencing were designed using the Ensembl genome database (http://www.ensembl.org) and a customized interface to Primer3 (ROZEN and SKALETSKY 2000).
Marker selection and testing for mapping:
The panel of SNP markers, polymorphic between Brown Norway and Wistar rat strains, was extracted from the rat CASCAD candidate SNP database (GURYEV et al. 2004; http://cascad.niob.knaw.nl) and verified in the six parents (two tornado males and four BN females) of the mapping cross by sequencing. The rat genome was virtually divided into 90 bins of similar size and the final SNP panel contained 84 verified SNPs representing 67 of these bins. The cross scheme already elucidated the autosomal recessive manner of inheritance for the mutation, so only markers on the autosomes were included to map the mutation. In total, the SNP distribution patterns for 67 mutant F2 animals from the mapping cross were determined.
Scanning electron microscopy:
Tornado animals (Myo7atnd-1Hubr/Myo7atnd-1Hubr) (n = 7) and phenotypically normal littermates (Myo7atnd-1Hubr/+ or +/+) (n = 6) of 6 days, 10 days, 20 days, and 13 weeks of age were examined. Rats were anesthetized by i.p. injection of Nembutal (60 mg/kg) and intracardially perfusion fixed with 2.5% glutaraldehyde in 0.1 M sodium-cacodylate buffer (pH 7.4). Inner ears were dissected and postfixed overnight in the same fixative. After fixation for 1 hr in 2% osmium tetroxide in 0.1 M sodium-cacodylate buffer, the specimens were dehydrated, critical point dried, and sputter coated with gold. Specimens were examined in a Jeol 6310 scanning electron microscope operating at 15 kV.
Light microscopy:
Pigmented tornado animals (Myo7atnd-1Hubr/Myo7atnd-1Hubr) (n = 2), derived from a cross with Brown Norway animals and having a crossing over between the albino and tornado locus, and heterozygous, pigmented littermates (Myo7atnd-1Hubr/+) (n = 2) of 5 weeks of age were sacrificed. The eyes were dissected, fixed in buffered formalin overnight, and embedded in paraffin. Sections of 6 µm through the retina were prepared and stained with hematoxylin/eosin and examined using a Nikkon Eclipse 6600 light microscope.
Auditory brain-stem response measurements:
Auditory brainstem response measurements (ABR) were performed in a soundproof room with low reverbation. Needle electrodes were placed on M1 and M2 (left and right mastoids) and referred to Cz (vertex) to record the auditory-evoked potentials. A ground electrode was placed halfway on the tail of the rat. Interelectrode impedances were measured before and after each measurement (< 8 kohm). Click stimuli were presented in a soundfield by placing the loudspeakers 5 cm in front of each ear. The loudness levels at the position of the ear were measured and calibrated with a Bruel and Kjaer 2203 sound pressure level (SPL) meter. All thresholds were corrected afterward for the soundfield setup by 7 dB (SPL). Before the measurements were made, the rats were i.p. injected with Nimatek (100 mg/kg) anesthetics. A standard-evoked potential recording system (Synergy, Oxford Instruments) was used to present 100-µsec click stimuli with a fixed stimulation rate of 20 Hz. The analysis time was set at 15 msec from the onset of the click with a 1.5-msec prestimulus time to assess the baseline. The recorded EEG signals were high-pass filtered at 100 Hz and low-pass filtered at 3 kHz; an automatic artifact rejection and a 60-Hz notch-filter were used to obtain auditory brain-stem responses from contra- and ipsilateral stimulation sites. The EEG signals were averaged for different stimulation levels according to standard audiometrical top-down procedures, starting at 90 dB (SPL), uncorrected for the soundfield. Peaks were identified according to the Jewett and Williston nomenclature (JEWETT and WILLISTON 1971). The auditory hearing threshold was defined as the level (in decibels) at which no reproducible responses were visually recognized in the responses obtained from the ipsilateral measured ear.
| RESULTS |
|---|
|
|
|---|
|
Mapping cross:
To identify the genetic defect underlying the rat tornado phenotype, we set up a mapping cross using a Brown Norway background. The causal mutation was introduced in a Wistar background (SMITS et al. 2004) and the Brown Norway strain is genetically the most distant compared to other commonly used laboratory rat strains (CANZIAN 1997; THOMAS et al. 2003), making it the best strain for mapping purposes. Ten F1 intercrosses were set up to restore the phenotype. In the first mating round, we obtained 117 F2 animals, of which 34 displayed the tornado phenotype (not shown). Strikingly, all tornado animals were found to be albino, whereas none of the pigmented (brown or black) animals showed the phenotype, indicating linkage to the gene causing albinism in the Wistar strain (c), which is located on chromosome 1 (Tyr). Two albino animals did not show the tornado phenotype. Considering these animals to be crossing overs, the genetic distance between the mutation and Tyr was estimated to be
3 cM.
Mapping the tornado mutation with the whole-genome SNP mapping panel:
A genome-wide SNP mapping panel (Brown Norway vs. Wistar) was constructed to independently confirm linkage to chromosome 1. Therefore, the rat genome was distributed in 90 bins of equal size from which candidate SNPs (GURYEV et al. 2004; http://cascad.niob.knaw.nl) were selected. Although some candidate SNPs could be selected on the basis of Wistar mRNA data vs. Brown Norway whole genome shotgun (WGS) sequencing data, the majority of the candidate SNPs were mined from Sprague Dawley EST data vs. Brown Norway WGS data. All candidate SNPs were tested in the six founders (two Wistar males and four BN females) of the mapping cross, resulting in a final SNP panel containing 84 verified SNPs distributed over 67 different bins (Figure 2a).
|
2.3 cM proximal to rs8173521.
Identification of the mutation by candidate gene approach:
To identify candidate genes in the remaining genomic interval, we mapped the orthologs of known human and mouse deafness genes on the rat genome (Table 1). Five human genes were found to have orthologs on rat chromosome 1, with Myo7a, encoding an unconventional myosin, closest to the albino gene and the rs8173521 SNP marker in the rat. Resequencing all 47 coding exons of Myo7a (Ensembl ID: ENSRNOT00000019053; Figure 3a) revealed an A-to-T transversion (position 362) that completely segregates with the tornado phenotype in all crosses (Figure 3b). This mutation (Myo7atnd-1Hubr) introduces a premature stopcodon in exon 5 in the middle of the myosin head encoding sequence and thereby most likely results in a complete loss of function of the gene. Humans carrying mutations in MYO7A are known to suffer from Usher syndrome type IB, which is characterized by a profound congenital sensorineural hearing loss, constant vestibular dysfunction, and prepubertal onset of retinitis pigmentosa (WEIL et al. 1995). Most human disease-causing mutations, including premature stopcodons, deletions, and missense mutations, are located in the amino-terminal end of the motor domain of the protein. The first alleles of the shaker-1 mice that were cloned were found to be two missense mutations and a splice acceptor site mutation in the region encoding the myosin head of Myo7a (GIBSON et al. 1995).
|
|
|
|
Similar to LIU et al. (1998), we found an absence of melanosomes in the apical processes of retinal pigment epithelium in a tornado background at 5 weeks of age (Figure 6a; control is Figure 6b). However, both pigmented and albino tornado rats did not show any signs of retinal degeneration at 20 weeks of age (data not shown).
|
| DISCUSSION |
|---|
|
|
|---|
The genome scan carried out using our SNP panel pointed toward a region on chromosome 1 containing Myo7a, the ortholog of the human Usher syndrome type 1B gene. Resequencing of the coding region of this gene in the tornado rat identified a nonsense mutation in the middle of the core domain, the myosin head. Human patients with Usher syndrome type 1B, also harboring mutations in the myosin head, suffer from profound congenital deafness (WEIL et al. 1995). Shaker-1, the mouse model for Usher syndrome type 1B, also displays severe congenital hearing impairment due to typical neuroepithelial-type cochlear defects (GIBSON et al. 1995). In 1998, SELF et al. (1998) described the correlation between the nature of the mutation, the severity of stereocilia disorganization, and electrophysiological response in three different alleles of Myo7a in the mouse. The most severe disruption of development of the stereocilia was observed in Myo7a816SB, a mutant lacking 10-amino-acid residues of the core of the motor head. These animals showed complete absence of stimulus-related cochlear potentials. Mice with a relatively mild shaker-1 phenotype (Myo7a6J) already show prenatal disorganization of stereocilia in the organ of Corti, whereas the microvilli at the upper surface of the hair cell, from which the stereocilia develop, are unaffected at embryonic day 16.5. The tornado rat allele described here (Myo7atnd-1Hubr) is likely to resemble the severe mouse and the common human alleles, as the premature stopcodon in the beginning of the gene is expected to result in complete loss of gene function. Indeed, in the tornado rat, stereocilia disorganization is obvious at 6 days of age and results in complete degeneration of cochlear hair cells within 1 month after birth. Furthermore, measurements of brain-stem responses to auditory stimuli suggest that tornado animals are deaf throughout life.
Taken together, the identification of the first rat model for Usher syndrome type 1B may contribute to the further understanding of the molecular mechanisms underlying Usher syndrome type IB and healthy and diseased inner ear and eye function in general. A major advantage of a rat model over a mouse model for studying inner ear function may be the size and accessibility of the organism, for example, for cochlear implant studies (VISCHER et al. 1997). Finally, the Myo7atnd-1Hubr mutant described here is the first rat model induced by ENU mutagenesis that is cloned by forward genetics, providing proof of principle for systematic forward genetics in the rat. Large-scale phenotype-driven screens in the rat have the potency to result in important new insights in the function of genes in the development of complex disease and higher brain functions, for which the rat currently is the best-suited model organism.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| LITERATURE CITED |
|---|
|
|
|---|
AHMED, Z. M., T. N. SMITH, S. RIAZUDDIN, T. MAKISHIMA, M. GHOSH et al., 2002 Nonsyndromic recessive deafness DFNB18 and Usher syndrome type IC are allelic mutations of USHIC. Hum. Genet. 110: 527531.[CrossRef][Medline]
ALAGRAMAM, K. N., C. L. MURCIA, H. Y. KWON, K. S. PAWLOWSKI, C. G. WRIGHT et al., 2001 The mouse Ames waltzer hearing-loss mutant is caused by mutation of Pcdh15, a novel protocadherin gene. Nat. Genet. 27: 99102.[Medline]
BOCKAMP, E., M. MARINGER, C. SPANGENBERG, S. FEES, S. FRASER et al., 2002 Of mice and models: improved animal models for biomedical research. Physiol. Genomics 11: 115132.
BROWN, S. D., and R. BALLING, 2001 Systematic approaches to mouse mutagenesis. Curr. Opin. Genet. Dev. 11: 268273.[CrossRef][Medline]
BROWN, S. D., and P. M. NOLAN, 1998 Mouse mutagenesis-systematic studies of mammalian gene function. Hum. Mol. Genet. 7: 16271633.
CANZIAN, F., 1997 Phylogenetics of the laboratory rat Rattus norvegicus. Genome Res. 7: 262267.
CHWALISZ, W. T., B. U. KOELSCH, A. KINDLER-ROHRBORN, H. J. HEDRICH and D. WEDEKIND, 2003 The circling behavior of the deafblind LEW-ci2 rat is linked to a segment of RNO10 containing Myo15 and Kcnj12. Mamm. Genome 14: 620627.[CrossRef][Medline]
COX, R. D., and S. D. BROWN, 2003 Rodent models of genetic disease. Curr. Opin. Genet. Dev. 13: 278283.[CrossRef][Medline]
GEAL-DOR, M., S. FREEMAN, G. LI and H. SOHMER, 1993 Development of hearing in neonatal rats: air and bone conducted ABR thresholds. Hear. Res. 69: 236242.[CrossRef][Medline]
GIBBS, D., J. KITAMOTO and D. S. WILLIAMS, 2003 Abnormal phagocytosis by retinal pigmented epithelium that lacks myosin VIIa, the Usher syndrome 1B protein. Proc. Natl. Acad. Sci. USA 100: 64816486.
GIBBS, R. A., G. M. WEINSTOCK, M. L. METZKER, D. M. MUZNY, E. J. SODERGREN et al., 2004 Genome sequence of the brown Norway rat yields insights into mammalian evolution. Nature 428: 493521.[CrossRef][Medline]
GIBSON, F., J. WALSH, P. MBURU, A. VARELA, K. A. BROWN et al., 1995 A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 374: 6264.[CrossRef][Medline]
GREENHOUSE, D. D., M. W. F. FESTING, S. HASAN and A. L. COHEN, 1990 Catalog of inbred strains of rats, pp. 411480 in Genetic Monitoring of Inbred Strains of Rats: A Manual on Colony Management, Basic Monitoring Techniques, and Genetic Variants of the Laboratory Rat, edited by H. J. HEDRICH and M. ADAMS. Gustav Fisher Verlag, Stuttgart, Germany.
GURYEV, V., E. BEREZIKOV, R. MALIK, R. H. PLASTERK and E. CUPPEN, 2004 Single nucleotide polymorphisms associated with rat expressed sequences. Genome Res. 14: 14381443.
HEDRICH, H. J., 2000 History, strains, and models, pp. 316 in The Handbook of Experimental Animals: The Laboratory Rat, edited by G. J. KRINKE. Academic Press, San Diego.
JACOB, H. J., and A. E. KWITEK, 2002 Rat genetics: attaching physiology and pharmacology to the genome. Nat. Rev. Genet. 3: 3342.[CrossRef][Medline]
JACOB, H. J., A. PETTERSSON, D. WILSON, Y. MAO, A. LERNMARK et al., 1992 Genetic dissection of autoimmune type I diabetes in the BB rat. Nat. Genet. 2: 5660.[CrossRef][Medline]
JEWETT, D. L., and J. S. WILLISTON, 1971 Auditory-evoked far fields averaged from the scalp of humans. Brain 94: 681696.
KEAYS, D. A., and P. M. NOLAN, 2003 N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders. Eur. J. Pharmacol. 480: 205217.[CrossRef][Medline]
KURAMOTO, T., M. KUWAMURA and T. SERIKAWA, 2004 Rat neurological mutations cerebellar vermis defect and hobble are caused by mutations in the netrin-1 receptor gene Unc5h3. Brain Res. Mol. Brain Res. 122: 103108.[Medline]
KURIMA, K., L. M. PETERS, Y. YANG, S. RIAZUDDIN, Z. M. AHMED et al., 2002 Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat. Genet. 30: 277284.[CrossRef][Medline]
LIU, X., B. ONDEK and D. S. WILLIAMS, 1998 Mutant myosin VIIa causes defective melanosome distribution in the RPE of shaker-1 mice. Nat. Genet. 19: 117118.[CrossRef][Medline]
LIU, X., I. P. UDOVICHENKO, S. D. BROWN, K. P. STEEL and D. S. WILLIAMS, 1999 Myosin VIIa participates in opsin transport through the photoreceptor cilium. J. Neurosci. 19: 62676274.
MARSZALEK, J. R., X. LIU, E. A. ROBERTS, D. CHUI, J. D. MARTH et al., 2000 Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell 102: 175187.[CrossRef][Medline]
MBURU, P., M. MUSTAPHA, A. VARELA, D. WEIL, A. EL-AMRAOUI et al., 2003 Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31. Nat. Genet. 34: 421428.[CrossRef][Medline]
NICKERSON, D. A., V. O. TOBE and S. L. TAYLOR, 1997 PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25: 27452751.
O'BRIEN, T. P., and W. N. FRANKEL, 2004 Moving forward with chemical mutagenesis in the mouse. J. Physiol. 554: 1321.
OUYANG, X. M., X. J. XIA, E. VERPY, L. L. DU, A. PANDYA et al., 2002 Mutations in the alternatively spliced exons of USH1C cause non-syndromic recessive deafness. Hum. Genet. 111: 2630.[CrossRef][Medline]
PUJOL, R., M. LAVIGNE-REBILLARD and M. LENOIR, 1998 Development of sensory and neural structures in the mammalian cochlea, pp. 146192 in Development of the Auditory System, edited by E. W. RUBEL, A. N. POPPER and R. R. FAY. Springer-Verlag, New York.
RAPP, J. P., 2000 Genetic analysis of inherited hypertension in the rat. Physiol. Rev. 80: 135172.
ROZEN, S., and H. SKALETSKY, 2000 Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132: 365386.[Medline]
SELF, T., M. MAHONY, J. FLEMING, J. WALSH, S. D. BROWN et al., 1998 Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development 125: 557566.[Abstract]
SHEPEL, L. A., H. LAN, J. D. HAAG, G. M. BRASIC, M. E. GHEEN et al., 1998 Genetic identification of multiple loci that control breast cancer susceptibility in the rat. Genetics 149: 289299.
SMITS, B. M., J. MUDDE, R. H. PLASTERK and E. CUPPEN, 2004 Target-selected mutagenesis of the rat. Genomics 83: 332334.[CrossRef][Medline]
THOMAS, M. A., C. F. CHEN, M. I. JENSEN-SEAMAN, P. J. TONELLATO and S. N. TWIGGER, 2003 Phylogenetics of rat inbred strains. Mamm. Genome 14: 6164.[CrossRef][Medline]
VAN DER WEYDEN, L., D. J. ADAMS and A. BRADLEY, 2002 Tools for targeted manipulation of the mouse genome. Physiol. Genomics 11: 133164.
VISCHER, M., A. HAENGGELI, J. ZHANG, M. PELIZZONE, R. HAUSLER et al., 1997 Effect of high-frequency electrical stimulation of the auditory nerve in an animal model of cochlear implants. Am. J. Otol. 18: S27S29.[Medline]
WANG, A., Y. LIANG, R. A. FRIDELL, F. J. PROBST, E. R. WILCOX et al., 1998 Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 280: 14471451.
WAYNE, S., N. G. ROBERTSON, F. DECLAU, N. CHEN, K. VERHOEVEN et al., 2001 Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum. Mol. Genet. 10: 195200.
WEIL, D., S. BLANCHARD, J. KAPLAN, P. GUILFORD, F. GIBSON et al., 1995 Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 374: 6061.[CrossRef][Medline]
WILSON, S. M., D. B. HOUSEHOLDER, V. COPPOLA, L. TESSAROLLO, B. FRITZSCH et al., 2001 Mutations in Cdh23 cause nonsyndromic hearing loss in waltzer mice. Genomics 74: 228233.[CrossRef][Medline]
ZAN, Y., J. D. HAAG, K. S. CHEN, L. A. SHEPEL, D. WIGINGTON et al., 2003 Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. Biotechnol. 21: 645651.[CrossRef][Medline]
ZIMDAHL, H., G. NYAKATURA, P. BRANDT, H. SCHULZ, O. HUMMEL et al., 2004 A SNP map of the rat genome generated from cDNA sequences. Science 303: 807.
ZWAENEPOEL, I., M. MUSTAPHA, M. LEIBOVICI, E. VERPY, R. GOODYEAR et al., 2002 Otoancorin, an inner ear protein restricted to the interface between the apical surface of sensory epithelia and their overlying acellular gels, is defective in autosomal recessive deafness DFNB22. Proc. Natl. Acad. Sci. USA 99: 62406245.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |